Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Carboplatin in Patients With Advanced Solid Tumors
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2016
At a glance
- Drugs Cetuximab (Primary) ; Carboplatin; Fluorouracil
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 25 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 20 Aug 2015 Planned End Date changed from 1 Oct 2016 to 1 Sep 2015 as reported by ClinicalTrials.gov.
- 20 Aug 2015 Planned primary completion date changed from 1 Oct 2016 to 1 May 2015 as reported by ClinicalTrials.gov.